Published in
Elsevier, Drug and Alcohol Dependence, (151), p. 236-240, 2015
DOI: 10.1016/j.drugalcdep.2015.03.035
Links
- ORCID
- Elsevier
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt
Journal article published in 2015 by
Jennifer J. Ware,
Paul Aveyard 
,
Peter Broderick,
Richard S. Houlston ,
Timothy Eisen,
Marcus R. Munafò
,
Peter Broderick,
Richard S. Houlston ,
Timothy Eisen,
Marcus R. Munafò
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
•We explore the impact of rs1051730 on nicotine replacement therapy (NRT) use in a smoking cessation trial.•Outcomes were NRT prescription adherence rate (%) and daily consumption (mg).•rs1051730 was associated with both outcomes at 7 days post quit attempt.•Each copy of the minor allele corresponded to a 1 mg decrease in daily NRT consumption.•No evidence of effect of genotype on either outcome observed at 28 days.